BEAT
BioTelemetry, Inc.
BEAT
BEAT
Delisted
BEAT was delisted on the 8th of February, 2021.
211 hedge funds and large institutions have $884M invested in BioTelemetry, Inc. in 2017 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 79 increasing their positions, 71 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5% more capital invested
Capital invested by funds: $840M → $884M (+$44.3M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
211
Holding in Top 10
3
Calls
$12.1M
Puts
$7.22M
Top Buyers
| 1 | +$36M | |
| 2 | +$13.3M | |
| 3 | +$10.1M | |
| 4 |
BlackRock
New York
|
+$8.17M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.9M |
Top Sellers
| 1 | -$12M | |
| 2 | -$7.42M | |
| 3 | -$6.77M | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$6.45M |
| 5 |
MPAM
Monarch Partners Asset Management
Boston,
Massachusetts
|
-$6.2M |